Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.27% -0.11% 164.86M 7100.43
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
2.59% 96.21% -7.473M Upgrade

Basic Info

Investment Strategy
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Adaptive Wealth Strategies U.S. Factor Index (the "index"). The fund invests at least 80% of its total assets in the securities of the index. Its 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The index is designed to dynamically allocate across three sub-indices that provide exposure to U.S. equities that exhibit characteristics of one of three primary factors: value, momentum and low volatility. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Value
Category Index Russell Mid Cap Value TR USD
Prospectus Objective Growth
Fund Owner Firm Name Global X Funds
Prospectus Benchmark Index
Adaptive Wealth Strategies US Ft TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Nam To 3.69 yrs
Wayne Xie 3.17 yrs
Kimberly Chan 2.89 yrs
Vanessa Yang 1.33 yrs
Sandy Lu 0.08 yrs
William Helm 0.08 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 47
-7.473M
-3.396B Category Low
2.509B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of April 30, 2022

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of May 20, 2022. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
24.06%
1.27%
27.46%
-6.94%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.67%
-12.48%
25.80%
14.61%
-14.61%
23.72%
2.38%
30.81%
-7.34%
-2.42%
24.38%
12.60%
-10.90%
24.72%
-4.13%
33.55%
-6.98%
-7.99%
28.71%
2.79%
-9.58%
30.37%
5.73%
35.17%
-12.54%
-5.65%
21.10%
13.11%
-14.67%
28.20%
11.10%
34.32%
-11.88%
As of May 20, 2022.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (5-20-22) 2.59%
30-Day SEC Yield (4-29-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 19.15
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of May 19, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of May 19, 2022

Asset Allocation

As of May 19, 2022.
Type % Net % Long % Short
Cash -0.00% Upgrade Upgrade
Stock 100.0% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Pfizer Inc 4.13% 52.86 0.74%
Berkshire Hathaway Inc Class B 3.37% 310.14 2.00%
Chevron Corp 2.93% 171.76 2.35%
Eli Lilly and Co 2.86% 302.71 1.29%
Exxon Mobil Corp 2.85% 93.85 2.17%
AbbVie Inc 2.76% 148.01 -1.99%
UnitedHealth Group Inc 2.41% 492.09 1.31%
ConocoPhillips 2.27% 109.22 4.00%
Costco Wholesale Corp 2.26% 429.72 3.19%
NVIDIA Corp 2.20% 168.96 1.21%

Basic Info

Investment Strategy
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Adaptive Wealth Strategies U.S. Factor Index (the "index"). The fund invests at least 80% of its total assets in the securities of the index. Its 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The index is designed to dynamically allocate across three sub-indices that provide exposure to U.S. equities that exhibit characteristics of one of three primary factors: value, momentum and low volatility. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Value
Category Index Russell Mid Cap Value TR USD
Prospectus Objective Growth
Fund Owner Firm Name Global X Funds
Prospectus Benchmark Index
Adaptive Wealth Strategies US Ft TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Nam To 3.69 yrs
Wayne Xie 3.17 yrs
Kimberly Chan 2.89 yrs
Vanessa Yang 1.33 yrs
Sandy Lu 0.08 yrs
William Helm 0.08 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (5-20-22) 2.59%
30-Day SEC Yield (4-29-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 19.15
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of May 19, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of May 19, 2022

Fund Details

Key Dates
Inception Date 8/24/2018
Last Annual Report Date 11/30/2021
Last Prospectus Date 4/1/2021
Attributes
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0